Nektar Therapeutics (NKTR) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Jennifer Ruddock -- Senior Vice President, Strategy and Corporate Affairs Howard
Nektar Therapeutics (NASDAQ: NKTR) Q1 2020 Earnings Call Transcript
Categories
Biotechnology
Amarin (AMRN) stock to remain within a tight range until the end of Vascepa litigation
The patent war between Amarin (NASDAQ: AMRN) and the generic companies for cardiovascular drug Vascepa continues to be a headwind for Amarin.
Affimed N.V. (NASDAQ: AFMD) Q1 2020 Earnings Call Transcript
Affimed N.V. (AFMD) Q1 2020 earnings call dated Jun. 23, 2020 Corporate Participants: Alexander Fudukidis -- Head of Investor Relations Adi Hoess -- Chief Executive Officer
Eli Lilly (LLY) appears to be on a strong footing with COVID-19 drug development efforts
Eli Lilly & Co.’s (NYSE: LLY) shares have gained 29% since the beginning of the year and 16% over the past three
FibroGen Inc (NASDAQ: FGEN) Q1 2020 Earnings Call Transcript
FibroGen Inc (FGEN) Q1 2020 earnings call dated May 08, 2020 Corporate Participants: Michael Tung -- Corporate Strategy Investor Relations Enrique Conterno -- Chief Executive Officer
Ionis Pharmaceuticals Inc. (NASDAQ: IONS) Q1 2020 Earnings Call Transcript
Ionis Pharmaceuticals Inc. (IONS) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Wade Walke, Ph.D. -- Vice President, Investor Relations Brett P.
Xenon Pharmaceuticals Inc (NASDAQ: XENE) Q1 2020 Earnings Call Transcript
Xenon Pharmaceuticals Inc (XENE) Q1 2020 earnings call dated May 21, 2020 Corporate Participants: Jodi Regts -- Vice President, Corporate Affairs and Investor Relations.
Karyopharm Therapeutics Inc (NASDAQ: KPTI) Q1 2020 Earnings Call Transcript
Karyopharm Therapeutics Inc (KPTI) Q1 2020 earnings call dated May 05, 2020 Corporate Participants: Ian Karp -- Vice President, Investor and Public Relations Michael
Akebia Therapeutics Inc (NASDAQ: AKBA) Q1 2020 Earnings Call Transcript
Akebia Therapeutics Inc (AKBA) Q1 2020 earnings call dated May 05, 2020 Corporate Participants: Kristen Sheppard -- Vice President, Investor Relations John Butler -- President and
Rallies you may have missed: 6 stocks that soared in 2020
This year, we saw long red candles replacing clowns as the ultimate symbol of horror. It has given sleepless nights to not
Incyte Corp (NASDAQ: INCY) Q1 2020 Earnings Call Transcript
Incyte Corp (INCY) Q1 2020 earnings call dated May 05, 2020 Corporate Participants: Michael Booth -- Division Vice President-Investor Relations & Corporate Responsibility Herve
Moderna Inc (NASDAQ: MRNA) Q1 2020 Earnings Call Transcript
Moderna Inc (MRNA) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane Bancel -- Chief Executive Officer
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q1 2020 Earnings Call Transcript
Corcept Therapeutics Incorporated (CORT) Q1 2020 earnings call dated May 04, 2020 Corporate Participants: Charles Robb -- Chief Financial Officer Joseph K Belanoff -- Chief Executive
Moderna (NASDAQ: MRNA) SARS-CoV-2 Vaccine Interim Phase 1 Data Call Transcript
Moderna Inc (MRNA) Q1 2019 interim phase 1 data conference call dated May. 18, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations
Novo Nordisk A/S (NYSE: NVO) Q1 2020 Earnings Call Transcript
Novo Nordisk A/S (NVO) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Lars Fruergaard Jorgensen -- President and Chief Executive Officer Mads
Moderna (MRNA) soars to a new 52-week high on positive phase 1 COVID-19 vaccine data
The entire world is waiting for some good news on a vaccine for the novel coronavirus. So far the global pandemic has
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Q1 2020 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (AUPH) Q1 2020 earnings call dated May. 14, 2020 Corporate Participants: Glenn Schulman -- Head of Investor Relations and Corporate Communications
Palatin is looking for new collaborations amid AMAG’s divestiture of Vyleesi
When most of the companies were discussing how they got impacted by the deadly virus and the uncertainties they faced in the
Veru Inc is venturing into COVID-19 vaccine hunt
Veru Inc (NASDAQ: VERU) is the latest company to jump into the bandwagon of firms around the world vying for a drug
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Q1 2020 Earnings Call Transcript
Catalyst Pharmaceuticals Inc (CPRX) Q1 2020 earnings call dated May 12, 2020 Corporate Participants: Alicia Grande -- Vice President, Chief Financial Officer and Treasurer
INOVIO Pharmaceuticals expects results from initial trials for COVID-19 vaccine next month
INOVIO Pharmaceuticals (NASDAQ: INO), which is among the frontrunners in developing a vaccine for the coronavirus disease, said during its post-earnings conference